Finally, following the same method as in31, we compared the median values of the IFN-γ signature score, the IMS score, and their ratio with objective response rates (ORRs) to anti-PD-1 therapies for cancer types with efficacy performance data available32 to get an educated guess of the applicability of these scores as potential biomarkers for immunotherapy. Here, IFNG is linked to cancer.